Details of the Drug

General Information of Drug (ID: DMTUS0Y)

Drug Name	Imidazopyridine and triazolopyridine compound 1
Synonyms	PMID28067079-Compound-105
Drug Type	Small molecular drug
Structure
Structure	3D MOL	2D MOL
#Ro5 Violations (Lipinski): 0	Molecular Weight (mw)	367.3
	Logarithm of the Partition Coefficient (xlogp)	2.5
	Rotatable Bond Count (rotbonds)	4
	Hydrogen Bond Donor Count (hbonddonor)	1
	Hydrogen Bond Acceptor Count (hbondacc)	7
Chemical Identifiers	Formula C18H11F2N5O2 IUPAC Name N-(5-fluoropyridin-2-yl)-6-(5-fluoropyridin-3-yl)oxyimidazo[1,2-a]pyridine-8-carboxamide Canonical SMILES C1=CC(=NC=C1F)NC(=O)C2=CC(=CN3C2=NC=C3)OC4=CC(=CN=C4)F InChI InChI=1S/C18H11F2N5O2/c19-11-1-2-16(23-8-11)24-18(26)15-6-14(10-25-4-3-22-17(15)25)27-13-5-12(20)7-21-9-13/h1-10H,(H,23,24,26) InChIKey GVUNIJCXLHRUNZ-UHFFFAOYSA-N
Cross-matching ID	PubChem CID 118103874 TTD ID D03ZXG

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Metabotropic glutamate receptor 5 (mGluR5)	TTHS256	GRM5_HUMAN	Modulator	[1]

------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
Metabotropic glutamate receptor 5 (mGluR5)	DTT	GRM5	9.81E-07	-0.26	-0.54

Molecular Expression Atlas (MEA)

Jump to Detail Molecular Expression Atlas of This Drug

References

1	mGlu5 negative allosteric modulators: a patent review (2013 - 2016).Expert Opin Ther Pat. 2017 Jun;27(6):691-706.